Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RIVACAST : RIVAroxaban Versus Low-molecular Weight Heparinin Patients With Lower Limb Trauma Requiring Brace or CASTing

NCT06195540 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT06195540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06195540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RIVACAST : RIVAroxaban Versus Low-molecular Weight Heparinin Patients With Lower Limb Trauma Requiring Brace or CASTing
Lead sponsor
University Hospital, Angers
Phase
Phase 3
Overall status
Recruiting
Start date
July 19, 2024
Completion date
November 19, 2028
Enrollment
1,424 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, immobilisation, lower limb trauma, pulmonary embolism, thromboprophylaxis, venous thromboembolism